F33.1

Major depressive disorder, recurrent, moderate

Major Depressive Disorder, Recurrent, Moderate (F33.1) is a clinical diagnosis within the ICD-10 framework, characterizing an individual who has experienced multiple depressive episodes, with the current or most recent episode presenting with moderate severity. For a diagnosis of major depressive disorder, an individual must experience a period of at least two weeks during which there is either a persistently depressed mood or a significant loss of interest or pleasure (anhedonia) in nearly all activities, alongside at least four additional core symptoms. These additional symptoms include significant weight loss or gain or decrease/increase in appetite, insomnia or hypersomnia, psychomotor agitation or retardation, pervasive fatigue or loss of energy, feelings of worthlessness or excessive or inappropriate guilt, diminished ability to think or concentrate or indecisiveness, and recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt or a specific plan for committing suicide. The "recurrent" specifier indicates that the individual has experienced at least two major depressive episodes, separated by a period of at least two consecutive months during which the diagnostic criteria for a major depressive episode were not met. This distinguishes it from a single episode diagnosis and highlights the often chronic and relapsing nature of the illness for many individuals. The "moderate" specifier denotes that the severity of the current episode falls between mild and severe. This typically means that the number of symptoms and their intensity, or the degree of functional impairment, are more pronounced than in a mild episode but not as pervasive or incapacitating as in a severe episode. While the individual may experience significant distress and difficulty in social, occupational, or other important areas of functioning, they can generally manage some daily responsibilities, albeit with considerable effort. Suicidal ideation may be present but usually without specific plans or attempts. Accurate diagnosis of this specific severity and recurrence pattern is crucial for tailoring appropriate treatment strategies, which commonly involve a combination of psychotherapy, pharmacotherapy (antidepressants), and supportive interventions, aimed at achieving symptom remission, preventing relapse, and improving overall quality of life.

Clinical Symptoms

Persistent depressed mood for most of the day, nearly every day
Markedly diminished interest or pleasure in all, or almost all, activities (anhedonia)
Significant unintentional weight loss or gain, or decrease/increase in appetite
Insomnia (difficulty falling or staying asleep) or hypersomnia (sleeping too much)
Psychomotor agitation or retardation (observable by others)
Fatigue or loss of energy nearly every day
Feelings of worthlessness or excessive or inappropriate guilt
Diminished ability to think or concentrate, or indecisiveness
Recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt or specific plan
Noticeable functional impairment in social or occupational settings, but generally able to maintain some essential daily activities

Common Causes

Genetic predisposition and family history of depression
Neurobiological factors, including imbalances in neurotransmitters (e.g., serotonin, norepinephrine, dopamine)
Psychological factors, such as chronic stress, adverse life events, trauma, and negative cognitive patterns
Environmental factors, including social isolation, lack of social support, and childhood adversity
Certain medical conditions (e.g., chronic illnesses, hormonal imbalances) and medications
Substance use or abuse (e.g., alcohol, illicit drugs)

Documentation & Coding Tips

Clearly document the recurrent nature of the major depressive disorder and its current moderate severity, detailing specific symptoms and functional impairment according to DSM-5 criteria.

Example: Patient is a 45-year-old female with a history of recurrent major depressive disorder for the past 10 years, experiencing multiple prior episodes. She presents today with symptoms consistent with a moderate depressive episode for the past 3 months. She reports persistent depressed mood, anhedonia (unable to enjoy hobbies), significant fatigue affecting work performance, and difficulty concentrating leading to errors in her daily tasks. She denies suicidal ideation. Functional impairment score: GAF 55. This chronic, recurrent condition significantly impacts her quality of life and requires ongoing management. This moderate severity episode necessitates therapeutic intervention to prevent escalation. Dx: F33.1, Z87.810 (Personal history of other diseases of the circulatory system, to capture comorbidity if present for risk adjustment, or Z87.890 for general chronic condition history).

Billing Focus: Document 'recurrent' and 'moderate' severity to support the specific ICD-10 code F33.1. Quantify functional impairment (e.g., GAF score or specific examples of impact on work/social life) and duration of current episode. Include relevant comorbidities like anxiety or chronic pain (if applicable) for medical necessity and higher E/M level support.

Specify the treatment plan and patient's response to current or prior therapies, including psychotherapy and pharmacotherapy.

Example: Patient has been on Sertraline 100mg daily for 6 months. While previous episodes responded well, she reports minimal improvement during this current moderate episode, noting continued sleep disturbance (initial insomnia), psychomotor retardation, and a 10lb unintentional weight gain. Patient expresses interest in adding psychotherapy. We discussed CBT. Plan: Continue Sertraline 100mg. Refer to CBT. Follow-up in 4 weeks. Reviewed suicide risk (none noted today). This ongoing, partially responsive, moderate recurrent MDD requires multimodal treatment. The complexity of managing a recurrent, partially responsive MDD episode with current functional decline supports the medical necessity for ongoing treatment and a higher level of service. (Consider billing E/M based on medical decision making or time).

Billing Focus: Detailing medication management (dosage changes, side effects), psychotherapy referrals, and patient's response demonstrates the complexity of care and supports higher E/M coding. Documenting 'ongoing, partially responsive' justifies continued and potentially adjusted treatment. Clearly state if counseling/coordination of care dominates the visit time.

Differentiate F33.1 from other mood disorders, adjustment disorders, or medically induced depression by ruling out other causes.

Example: Patient denies recent significant stressors that would suggest an adjustment disorder. Thyroid function tests (TSH, free T4) are within normal limits (results reviewed), ruling out hypothyroidism as a primary cause of her depressive symptoms. No new medications initiated recently that could induce depression. Her symptom profile of persistent anhedonia, vegetative symptoms, and clear history of prior depressive episodes aligns with recurrent MDD rather than other etiologies. This diagnostic clarity is crucial for targeted treatment and accurate billing/risk adjustment. (Consider documenting other relevant negatives, e.g., 'no evidence of substance abuse contributing to current symptoms').

Billing Focus: Documenting that other potential causes have been ruled out (e.g., lab results, absence of substance use, lack of acute stressor) strengthens the medical necessity for the F33.1 diagnosis and supports accurate billing by justifying the diagnostic workup and specific treatment plan. It prevents down-coding or denial based on 'unspecified' or less severe diagnoses.

Relevant CPT Codes

99214 - Office or other outpatient visit, established patient
Appropriate for follow-up visits managing recurrent moderate MDD, especially when involving medication adjustments, psychotherapy referrals, assessment of functional decline, and coordination of care. The moderate severity and recurrent nature often require moderate medical decision making.
99204 - Office or other outpatient visit, new patient
Used for initial comprehensive evaluations of new patients presenting with suspected or confirmed recurrent moderate MDD, requiring a detailed history, examination, and establishment of a diagnosis and treatment plan.
90833 - Psychotherapy, 30 minutes with evaluation and management service
Many E/M visits for recurrent moderate MDD involve significant counseling and psychotherapy elements that exceed typical E/M components, such as cognitive behavioral therapy techniques or supportive therapy. This add-on code is used when psychotherapy is performed face-to-face for 16-37 minutes.
90836 - Psychotherapy, 45 minutes
Used when psychotherapy is the primary focus of the visit and lasts 38-52 minutes, which is common in managing the psychological aspects of recurrent moderate MDD.
90863 - Pharmacologic management, including prescription, use, and review of medication; when performed with psychotherapy and/or an E/M service
This add-on code is used by psychiatrists for the focused management of psychotropic medications, which is a key component of treating recurrent MDD, particularly during medication initiation, titration, or when managing side effects. While often included in E/M, explicit complex medication management may justify this code in some contexts if distinct from routine E/M.
99401 - Preventive medicine counseling and/or risk factor reduction intervention, individual, 15 minutes
Can be used for counseling on lifestyle modifications, stress management, or relapse prevention strategies for patients with recurrent MDD, which are crucial for long-term management.